# The Royal Pharmaceutical Society of Great Britain (Registration Rules) Order of Council 2007, Paragraph 31: Attendance of the public at hearings


(1) Subject to paragraph (2), hearings before the Committee shall be conducted in public.
(2) Where an issue under consideration relates to the health of the appellant or a third party, the hearing, or the relevant part of the hearing, that relates to that issue shall be conducted in private if the Committee is satisfied—
(a) having given the parties (where present), and any third party from whom the Committee considers it appropriate to hear, an opportunity to make representations; and
(b) having obtained the advice of a clinical adviser,
that the interest of the appellant or the third party in maintaining their privacy as regards that issue outweigh the public interest in holding the hearing, or the relevant part of the hearing, in public.
(3) The Committee may exclude from the whole or any part of a hearing any person whose conduct, in the opinion of the Committee, has disrupted or is likely to disrupt the hearing.

---
Source: https://www.legislation.gov.uk/uksi/2007/441/schedule/paragraph/31 (the official version)
Page: https://openlegislation.uk/royal-pharmaceutical-society-of-great-britain-registration-rules-order-of-council-2007/schedule/paragraph-31
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

